Search Results 1651-1660 of 16637 for vitamin toxicity

1. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

   Vitamin E treatment (≥ 800 IU/day) must not have been initiated after the qualifying liver biopsy was performed. Age and reproductive status: Men or women ...

2. Mayo Clinic Q and A: Aging and changing

   ... vitamins. Also, speak to your primary health care provider ... Certainly, there are other causes of memory loss, including medication interactions; vitamin ...

3. Antidepressants: Safe during pregnancy? - Mayo Clinic

   Medicines often are important for treating depression while pregnant. Weigh the risks and benefits with your health care team.

4. Publications - Jose R. Valery, M.D. - Mayo Clinic

   Assessment of Knowledge Regarding Risks and Benefits of the Use of Non-Vitamin K Antagonist Oral Anticoagulants. J Prim Care Community Health. 2022 Jan-Dec ...

5. Publications - Leslie V. Simon, D.O. - Mayo Clinic

   Lidocaine Toxicity. StatPearls Treasure Island (FL) StatPearls Publishing 2025 Jan View PubMed; Simon LV, Torp KD. Laryngeal Mask Airway. StatPearls Treasure ...

6. A Phase I Study of TAS-102 in Patients with Advanced Solid Tumors with Hepatic Impairment - Mayo Clinic

   Has unresolved toxicity of greater than or equal to CTCAE Grade 2 attributed to any prior therapies; Is a pregnant or lactating female. Participating Mayo ...

7. Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

   Current diagnosis of fulminant colitis and/or toxic megacolon. Subjects with disease limited to the rectum (ulcerative proctitis) during the screening ...

8. A Study to Compare the Effectiveness and Safety of Emixustat Hydrochloride with Placebo to Treat Macular Atrophy Secondary to Stargadt Disease - Mayo Clinic

   Current or previous participation in a study to treat STGD using a vitamin A derivative ≤ 6 months prior to Screening. Current or previous participation in ...

9. Tools to evaluate treatment tolerability in older patients with sarcoma - Mayo Clinic

   ... toxicity with therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

10. Publications - David C. Fipps, D.O. - Mayo Clinic

    2020; 20(5):34-35. Fipps DC, Rainey E. Psychotic Features Abated with Vitamin D Treatment in a Patient with Major Depressive Disorder. Case Rep Psychiatry ...